Uniplan Investment Counsel Inc. Purchases New Position in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Uniplan Investment Counsel Inc. has acquired a new position in Sabra Healthcare REIT, Inc., purchasing 188,533 shares valued at approximately $3,294,000, bringing its ownership to 0.08% of the company.
• Several institutional investors, including Hancock Whitney Corp and AQR Capital Management LLC, have also increased their stakes, indicating strong institutional interest in the stock.
• Analysts have raised their price targets for Sabra Healthcare REIT, with the average target now at $20.71 and an overall rating of "Moderate Buy."

Uniplan Investment Counsel Inc. acquired a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 188,533 shares of the real estate investment trust's stock, valued at approximately $3,294,000. Uniplan Investment Counsel Inc. owned 0.08% of Sabra Healthcare REIT as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Bank of New York Mellon Corp increased its holdings in Sabra Healthcare REIT by 1.8% in the first quarter. Bank of New York Mellon Corp now owns 4,114,215 shares of the real estate investment trust's stock valued at $71,875,000 after purchasing an additional 74,564 shares during the period. Nuveen LLC acquired a new stake in Sabra Healthcare REIT in the first quarter valued at $61,791,000. Janus Henderson Group PLC increased its holdings in Sabra Healthcare REIT by 23.1% in the fourth quarter. Janus Henderson Group PLC now owns 3,504,809 shares of the real estate investment trust's stock valued at $60,720,000 after purchasing an additional 657,950 shares during the period. Nuveen Asset Management LLC increased its holdings in Sabra Healthcare REIT by 30.8% in the fourth quarter. Nuveen Asset Management LLC now owns 3,378,733 shares of the real estate investment trust's stock valued at $58,520,000 after purchasing an additional 795,902 shares during the period. Finally, Wellington Management Group LLP increased its holdings in Sabra Healthcare REIT by 33.7% in the fourth quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock valued at $55,511,000 after purchasing an additional 808,207 shares during the period. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on SBRA shares. Truist Financial increased their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a report on Tuesday, September 2nd. BMO Capital Markets upped their price target on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research report on Monday, August 25th. JMP Securities upped their price target on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research report on Wednesday, August 6th. Scotiabank upped their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. Finally, Wells Fargo & Company upped their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research report on Wednesday, August 27th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $20.71.

Sabra Healthcare REIT Stock Up 1.1%

Shares of SBRA stock traded up $0.20 on Thursday, reaching $19.13. 1,656,848 shares of the company were exchanged, compared to its average volume of 2,439,190. The company has a market cap of $4.59 billion, a price-to-earnings ratio of 25.17, a PEG ratio of 1.52 and a beta of 0.88. The company has a 50-day moving average of $18.67 and a 200-day moving average of $17.93. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. Sabra Healthcare REIT, Inc. has a one year low of $15.60 and a one year high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. The company had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business's revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.3%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is 157.89%.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.